Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check4 days agoChange DetectedFooter revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows an updated revision label: v3.4.2 replaces the previous v3.4.1.SummaryDifference0.1%

- Check40 days agoChange DetectedA minor revision tag was updated from v3.4.0 to v3.4.1 on the page, with no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedUI/content updates include showing the glossary toggle and updating header/footer/version text: added 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the corresponding lowercased items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision on the page footer updated from v3.3.3 to v3.3.4, a minor metadata/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section added with Washington as a study site, the previous 'Washington Locations' entry was removed, and the page footer shows Revision: v3.3.3.SummaryDifference0.3%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.